PMC:7376974 / 5493-5810
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T11 | 13-17 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 51 | 127-139 | Chemical | denotes | nanovaccines |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T43 | 13-17 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T44 | 34-44 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 34-63 | http://purl.obolibrary.org/obo/GO_0002253 | denotes | activation of immune response |
| T14 | 48-63 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T36 | 28-169 | Sentence | denotes | Then, activation of immune response induced by HNMs, triggering the innate and the adaptive (e.g., nanovaccines) immunity, will be presented. |